Survey of primary drug resistance of Mycobacterium tuberculosis in Casablanca, Morocco

International Journal of Tuberculosis and Lung Disease

Volumn 1, Issue 4, 1997, Pages 309-313

  El Baghdadi, J ^a   Lazraq, R ^a   Ibrahimy, S ^a   Bouayad, Z ^b   Guinet, R ^a   Benslimane, A ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

Author keywords

Casablanca; Mycobacterium tuberculosis; Primary drug resistance; Survey; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; CHILD; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MOROCCO; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDY; RISK; STATISTICS; TUBERCULOSIS; URBAN POPULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CHILD; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOROCCO; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; PROSPECTIVE STUDIES; TUBERCULOSIS, MULTIDRUG-RESISTANT; URBAN POPULATION;

EID: 0031196683     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fox J L. Résurgence de la tuberculose multirésistante aux médicaments. Bull Ass Anc El Inst Pasteur 1992; 35: 117-122.
2. Grosset J. Fréquence et gravité actuelles de la résistance de Mycobacterium tuberculosis aux antibiotiques. Ann Inst Pasteur Actualités 1993; 4: 196-202.
3. Banal M, Nacir A, El Meziane A, Bouayad Z, Bahlaoui A. Le traitement de la tuberculose. Rev Mar Méd Santé 1988; 10: 1-2.
4. Othmani S. (National Tuberculosis Programme, Ministry of Public Health, Morocco), personal communication, 1995.
5. Direction de l'Epidemiologie et des Programmes Sanitaires. Bulletin d'epidémioiogie. Ministère de la Santé Publique (Morocco), Mars 1994; 12.
6. Direction de l'Epidémiologie et des Programmes Sanitaires. Bulletin d'épidémiologie. Ministère de la Santé Publique (Morocco), Janvier 1996; 17-20.
7. Dutt A K, Moers D, Stead W W. Smear- and culture-negative pulmonary tuberculosis: four month short-course chemotherapy. Am Rev Respir Dis 1989; 139: 867-870.
8. Hong Kong Chest Service/Tuberculosis Research Centre Madras/British Medical Research Council. A controlled trial of 3-month, 4-month and 6-month regimens of chemotherapy for sputumsmear-negative pulmonary tuberculosis. Results at 5 years. Am Rev Respir Dis 1989; 139: 871-876.
9. Gangadharam P R J. Drug resistance in mycobacteria. In: CRC Press Inc., Boca Raton, Florida USA, 1984; pp. 7-33.
10. Kleeberg H H, Koornhof H J, Palmhert H. Laboratory manual of tuberculosis methods. 2nd ed. revised by Nel E E, Kleeberg H H, Gatner E M S. Pretoria: TBRI, 1980.
11. Canetti G, Rist N, Grosset J. Mesure de la sensibilité du bacille tuberculeux aux drogues antibacillaires par la méthode des proportions. Rev Tuberc Pneumol 1963; 27: 217-272.
12. Canetti G, Le Lirzin M, Gay P, Thibier R, Kreis B, Grosset J. La résistance primaire dans la tuberculose pulmonaire de l'adulte en France. Rev Tuberc Pneumol 1972; 36: 337.
13. Cooreman J, Burghard G, Grosset J. La résistance du bacille de Koch aux antibacillaires dans le département du Bas-Rhin. Rev Fr Mal Resp 1983; 11: 699-704.
14. David H L, Feuillet A, Goh K S. Initial and primary drug resistance of tubercle bacilli in France during 1978-1984. In: M Casai ed., Mycobacteria of Clinical Interest, Elsevier Science Publishers BV (Biomedical Division) 1986; pp. 216-221.
15. Grosset J, Truffot-Pernot Ch. Etat actuel de la résistance de Mycobacterium tuberculosis aux antibiotiques. Let Infect 1988; 3: 369-377.
16. Ausina V, Riutort N, Vinado B, et al. Prospective study of drug resistant tuberculosis in a spanish urban population including patients at risk for HIV infection. Eur J Clin Microbiol Infect Dis 1995; 14: 105-110.
17. Bloch A B, Cauthen G M, Onorato I M, et al. Nationwide survey of drug resistant tuberculosis in the United States. JAMA 1994; 271: 665-671.
18. Khaled S, Boulahbal F. Enquête prospective sur la résistance primaire du bacille de la tuberculose aux antibiotiques. Méthodologie et résultats. Arch Inst Pasteur Algérie 1988; 56: 49-65.
19. Najah S, Tchekel I. Etude de la résistance du bacille tuberculeux dans la région de Sfax durant les années 1973 à 1975. Rev Fr Mal Resp 1978; 6: 179-182.
20. Zhang L X, Kan G Q, Tu D H, Li J S, Liu X X. Trend of initial drug resistance of tubercle bacilli isolated from new patients with pulmonary tuberculosis and its correlation with the tuberculosis programme in Beijing. Tubercle Lung Dis 1995; 76: 100-103.
21. Zaman R. Tuberculosis in Saudi Arabia : Initial and secondary drug resistance among indigenous and non indigenous populations. Tubercle 1991; 72: 51-55.
22. Jarralah J S, Elias A K, Al Hajjaj M S, Bukhari M S, Al Shareef A H M, Al-Shammari S A. High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tubercle Lung Dis 1992; 73: 113-115.
23. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. WHO/TB 1994; 178.